MétaCan
Menu
Back to cohort
Record W2159567726 · doi:10.1016/j.bbmt.2015.08.023

Transplant Outcomes for Children with T Cell Acute Lymphoblastic Leukemia in Second Remission: A Report from the Center for International Blood and Marrow Transplant Research

2015· article· en· W2159567726 on OpenAlexafffund
Michael J. Burke, Michael R. Verneris, Jennifer Le Rademacher, Wensheng He, Hisham Abdel‐Azim, Allistair Abraham, Jeffery J. Auletta, Mouhab Ayas, Valerie I. Brown, Mitchell S. Cairo, Ka Wah Chan, Miguel Ángel Díaz, Christopher C. Dvorak, R. Maarten Egeler, Lamis Eldjerou, Haydar Frangoul, Gregory M.T. Guilcher, Robert J. Hayashi, Ahmed Ibrahim, Kimberly A. Kasow, Wing Leung, Richard F. Olsson, Michael A. Pulsipher, Niketa C. Shah, Nirali N. Shah, Elizabeth Thiel, Julie‐An Talano, Carrie L. Kitko

Bibliographic record

VenueBiology of Blood and Marrow Transplantation · 2015
Typearticle
Languageen
FieldMedicine
TopicAcute Lymphoblastic Leukemia research
Canadian institutionsAlberta Children's HospitalHospital for Sick Children
FundersOffice of Naval ResearchNational Heart, Lung, and Blood InstituteTakeda OncologyHealth Resources and Services AdministrationMedacSwedish Orphan BiovitrumU.S. Department of Health and Human ServicesGlaxoSmithKlineKiadis PharmaMiltenyi BiotecOtsuka AmericaIncyteTherakosGenentechSeattle GeneticsNational Institutes of HealthFred Hutchinson Cancer Research CenterLeukemia and Lymphoma Society of CanadaChimerixU.S. Department of DefenseMedical College of WisconsinSanofiUniversity of UtahNational Institute of Allergy and Infectious DiseasesBlue Cross and Blue Shield AssociationUniversity of MinnesotaSigma-Tau PharmaceuticalsU.S. Public Health ServiceActinium PharmaceuticalsMillimanHistoGeneticsWellPointTeva Pharmaceutical IndustriesHealth ResearchNational Marrow Donor ProgramNational Cancer InstituteGenzymeSt. Baldrick's FoundationRoswell Park Cancer InstituteLeukemia and Lymphoma SocietyU.S. NavyCelgeneOsiris TherapeuticsMerckStemCyteTarix PharmaceuticalsAllos TherapeuticsAriad PharmaceuticalsOtsuka America PharmaceuticalAmgenBe The Match FoundationOnyx Pharmaceuticals
KeywordsMedicineHazard ratioBone marrowInternal medicineConfidence intervalCord bloodTransplantationGastroenterologyUmbilical cordSurgeryImmunology

Abstract

fetched live from OpenAlex

Survival for children with relapsed T cell acute lymphoblastic leukemia (T-ALL) is poor when treated with chemotherapy alone, and outcomes after allogeneic hematopoietic cell transplantation (HCT) is not well described. Two hundred twenty-nine children with T-ALL in second complete remission (CR2) received an HCT after myeloablative conditioning between 2000 and 2011 and were reported to the Center for International Blood and Marrow Transplant Research. Median age was 10 years (range, 2 to 18). Donor source was umbilical cord blood (26%), matched sibling bone marrow (38%), or unrelated bone marrow/peripheral blood (36%). Acute (grades II to IV) and chronic graft-versus-host disease occurred in, respectively, 35% (95% confidence interval [CI], 27% to 45%) and 26% (95% CI, 20% to 33%) of patients. Transplant-related mortality at day 100 and 3-year relapse rates were 13% (95% CI, 9% to 18%) and 30% (95% CI, 24% to 37%), respectively. Three-year overall survival and disease-free survival rates were 48% (95% CI, 41% to 55%) and 46% (95% CI, 39% to 52%), respectively. In multivariate analysis, patients with bone marrow relapse, with or without concurrent extramedullary relapse before HCT, were most likely to relapse (hazard ratio, 3.94; P = .005) as compared with isolated extramedullary disease. In conclusion, HCT for pediatric T-ALL in CR2 demonstrates reasonable and durable outcomes, and consideration for HCT is warranted.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.278
Threshold uncertainty score0.605

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.025
GPT teacher head0.302
Teacher spread0.277 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations37
Published2015
Admission routes2
Has abstractyes

Explore more

Same venueBiology of Blood and Marrow TransplantationSame topicAcute Lymphoblastic Leukemia researchFrench-language works237,207